Recro Pharma Inc.

NASDAQ: REPH · Real-Time Price · USD
2.09
-0.01 (-0.48%)
At close: Mar 22, 2022, 5:00 AM

Recro Pharma Revenue

Recro Pharma reported an annual revenue of $94.64M, reflecting a 4.9% growth. For the quarter ending December 31, 2023, Recro Pharma generated $27.72M in revenue.
Revenue (ttm)
$94.64M
Revenue Growth
4.9%
Price / Sales Ratio
2103.12
Revenue / Employee
$511.54K
Employees
185
Market Cap
177.42M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.